ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Zomedica Pharmaceuticals Corp

Zomedica Pharmaceuticals Corp (ZOM)

0.285
0.00
( 0.00% )
Updated: 19:00:00

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.285
Bid
0.11
Ask
0.45
Volume
-
0.00 Day's Range 0.00
0.285 52 Week Range 0.285
Market Cap
Previous Close
0.285
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
979,949,000
Dividend Yield
-
PE Ratio
-7.95
Earnings Per Share (EPS)
-0.04
Revenue
25.19M
Net Profit
-34.53M

About Zomedica Pharmaceuticals Corp

Sector
Testing Laboratories
Industry
Unit Inv Tr, Closed-end Mgmt
Headquarters
Ann Arbor, Michigan, USA
Founded
2016
Zomedica Pharmaceuticals Corp is listed in the Testing Laboratories sector of the TSX Venture Exchange with ticker ZOM. The last closing price for Zomedica Pharmaceuticals was $0.29. Over the last year, Zomedica Pharmaceuticals shares have traded in a share price range of $ 0.285 to $ 0.285.

Zomedica Pharmaceuticals currently has 979,949,000 shares outstanding. The market capitalization of Zomedica Pharmaceuticals is $279.29 million. Zomedica Pharmaceuticals has a price to earnings ratio (PE ratio) of -7.95.

ZOM Latest News

Sean Whelan Appointed to Board of Directors

ANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

Zomedica Announces Second Quarter 2021 Financial Results

ANN ARBOR, Mich., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...

Zomedica Announces 2021 Annual Meeting Results

ANN ARBOR, Mich., July 30, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...

Zomedica Provides Corporate Update

FOCUSED ON TRUFORMA® INSTRUMENT PLACEMENTS AND BUILDING DIRECT SALES ORGANIZATION ANN ARBOR, Mich., July 06, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the...

Zomedica Hires Vice President Business Development to Lead Acquisition and Licensing Efforts

Former Elanco Animal Health, Johnson & Johnson, Intuitive Surgical, and Enteromedics Business Development Executive Joins Team to Support Growth Opportunities ANN ARBOR, Mich., May 17, 2021...

Zomedica Announces First Quarter 2021 Financial Results

ANN ARBOR, Mich, May 12, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary health company creating point-of-care diagnostics products for dogs...

Zomedica to Build Direct Sales Force for TRUFORMA® Platform

ANN ARBOR, Mich., April 15, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

Zomedica Announces First Commercial Sale of Its Truforma® Platform

ANN ARBOR, Mich., March 16, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

Zomedica Retires Preferred Shares

ANN ARBOR, Mich., March 08, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

Zomedica Corp. Announces Year End 2020 Financial Results

ANN ARBOR, Mich., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.2850.2850.28500CS
4000.2850.2850.28500CS
12000.2850.2850.28500CS
26000.2850.2850.28500CS
52000.2850.2850.28500CS
156000.2850.2850.28500CS
260-0.155-35.22727272730.440.450.285140.30358376CS

ZOM - Frequently Asked Questions (FAQ)

What is the current Zomedica Pharmaceuticals share price?
The current share price of Zomedica Pharmaceuticals is $ 0.285
How many Zomedica Pharmaceuticals shares are in issue?
Zomedica Pharmaceuticals has 979,949,000 shares in issue
What is the market cap of Zomedica Pharmaceuticals?
The market capitalisation of Zomedica Pharmaceuticals is CAD 279.29M
What is the 1 year trading range for Zomedica Pharmaceuticals share price?
Zomedica Pharmaceuticals has traded in the range of $ 0.285 to $ 0.285 during the past year
What is the PE ratio of Zomedica Pharmaceuticals?
The price to earnings ratio of Zomedica Pharmaceuticals is -7.95
What is the cash to sales ratio of Zomedica Pharmaceuticals?
The cash to sales ratio of Zomedica Pharmaceuticals is 10.89
What is the reporting currency for Zomedica Pharmaceuticals?
Zomedica Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Zomedica Pharmaceuticals?
The latest annual turnover of Zomedica Pharmaceuticals is USD 25.19M
What is the latest annual profit for Zomedica Pharmaceuticals?
The latest annual profit of Zomedica Pharmaceuticals is USD -34.53M
What is the registered address of Zomedica Pharmaceuticals?
The registered address for Zomedica Pharmaceuticals is 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR, MICHIGAN, 48108
What is the Zomedica Pharmaceuticals website address?
The website address for Zomedica Pharmaceuticals is www.zomedica.com
Which industry sector does Zomedica Pharmaceuticals operate in?
Zomedica Pharmaceuticals operates in the UNIT INV TR, CLOSED-END MGMT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CTGCentenario Gold Corp
$ 0.03
(200.00%)
668.3k
CTACentaurus Energy Inc
$ 3.75
(111.86%)
6.15k
IDIdentillect Technologies Corp
$ 0.01
(100.00%)
2.08k
MVYMoovly Media Inc
$ 0.01
(100.00%)
39k
BYM.HBaymount Incorporated
$ 0.01
(100.00%)
2k
ADG.HArcus Development Group Inc
$ 0.005
(-66.67%)
11k
MAND.PMandeville Ventures Inc
$ 0.015
(-57.14%)
160k
AQSAequus Pharmaceuticals Inc
$ 0.005
(-50.00%)
7k
NNXNickel North Exploration Corp
$ 0.01
(-50.00%)
12k
KUR.HKure Technologies Inc
$ 0.02
(-42.86%)
4k
XBOTRealbotix Corp
$ 0.54
(-11.48%)
9.46M
QNCQuantum Emotion Corp
$ 0.65
(-27.78%)
6.92M
GPUSAlset AI Ventures Inc
$ 0.15
(-18.92%)
3.46M
KSKlondike Silver Corp
$ 0.01
(0.00%)
3.23M
MAHMarksmen Energy Inc
$ 0.01
(0.00%)
2.79M

Discussion

View Full Feed
surfkast surfkast 2 minutes ago
Blagman can say whatever he wants but he is not the spokesperson for the company. So it is meaningless. Jason Schlenk is the only one who can make an official announcement.
MWWC
Skankhunt43 Skankhunt43 3 minutes ago
Looks like someone hit a nerve. You don't seem to believe in yourself. I wonder why?
PSRU
barnyarddog barnyarddog 3 minutes ago
4.39 +1.01 (29.88%)
Volume: 106,954
Day Range: 3.3339 - 4.72
Last Trade Time: 3:35:29 PM EST
ROLR
peanutz peanutz 3 minutes ago
Beast mode ! 💪
UMAV
rodeoup rodeoup 3 minutes ago
Please let everyone know how many shares you have in this company you’re so agenda driven infatuated with, awww let me answer it for you zero, nada and Zilch!!!!
NBRI
LuckyCorsair23 LuckyCorsair23 3 minutes ago
Trump(in Florida)is super pro VTOL, xeri(I’m Florida) owns patents that the whole VTOL space will need(xti would only be a cherry on top). BUY BUY BUY
XERI
hankmanhub hankmanhub 3 minutes ago
Is anyone having large delays (as long as 1/2 to 1 minute or longer) in response time from iHub just to simply read a post? I often am now getting messages such as "can not reach site" when I try to read a post. This message then changes to the post once iHub is ready to send.
NWBO
capgain capgain 3 minutes ago
Thanks, but next weekend scares me to death. Detroit here we come lol

Hurts looked a little off, but he should be fine I think.
Skankhunt43 Skankhunt43 3 minutes ago
I also got a wimpy little private message from him. He doesn't like getting picked on 😂
PSRU
pos_stock_hoarder pos_stock_hoarder 4 minutes ago
https://assets.amuniversal.com/60dd0ee0ae8b013d878f005056a9545d
RickNagra RickNagra 4 minutes ago
Can we get to $5.55 before the close ?  All fives ?
FNMA
georgie18 georgie18 4 minutes ago
Nice move today on ONCO...🥳
ONCO
Manspider Manspider 4 minutes ago
$ASII$ is a “pink sheet” of course there are problems? OTC trading is not for the weak minded for sure! Patience… :-D
ASII
Skankhunt43 Skankhunt43 4 minutes ago
It's a list of 20 companies owned by a trip1 stock. You REALLY thought the list was 100% up to date?

You want Berkshire Hathaway? Then go buy Berkshire Hathaway.

You're sitting here acting like a company in this condition is unheard of.
PSRU
PonkenPlonken PonkenPlonken 5 minutes ago
I did!
then sold on Dec23.....
But did a few today too - so had a great time with this junk.
Judging by the timestamps - you did too.

Regards
PHIO
threewheeler threewheeler 5 minutes ago
KRTL ready to see some .08 for close
KRTL
Greedy G Greedy G 5 minutes ago
~bought 1/17 $533 calls @.06c way oversold 
QQQ
Slojab Slojab 5 minutes ago
Methinks she fibbed.
QEDN
Investor2014 Investor2014 5 minutes ago
Its not standard and as badger said at a minimum a completely unnecessary sentence or as we see worse.
AVXL
threewheeler threewheeler 6 minutes ago
KRTL ready to see some .08 for close
KRTL
Trooperstocks Trooperstocks 6 minutes ago
GREAT DAY Here for $SGTM!
SGTM
Monksdream Monksdream 6 minutes ago
STIM
Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience, Neuronetics is delivering more treatment options to patients and physicians by offering exceptional in-office treatments that produce extraordinary results. NeuroStar Adv
STIM
gumzsa gumzsa 6 minutes ago
Need support up in the $2.00-$3.00 range in order for most of us just to break even after the RS. Ben Quick doesn't answer emails either. So far he is doing a very bad job for loyal shareholders.
NFTM
BBANBOB BBANBOB 6 minutes ago
Hope we all still have teeth by then
CommodityCoverage CommodityCoverage 6 minutes ago
Targeting a projected global market opportunity of CAD$9.8B, Thiogenesis Therapeutics (TTI.v) is focused on addressing rare conditions including MELAS, Leigh Syndrome, Rett Syndrome, and Pediatric MASH with its lead product, TTI-0102. Poised to make a significant impact on the market, TTI is at the
TTI

Your Recent History

Delayed Upgrade Clock